Physician profile
Relief Jones
NPI 1679546188
$1,170.03
in general payments reported to CMS, 2019-2025
13 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26.05 · 2020: $29.42 · 2021: $214 · 2022: $37.93 · 2023: $165 · 2024: $248 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $862.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $417.17 | 2024-2025 | |
| Ocular Therapeutix, INC. | $161.37 | 2021 | |
| Abbvie INC. | $147.70 | 2023-2025 | |
| Amgen INC. | $121.63 | 2024 | Tepezza |
| Allergan, INC. | $93.09 | 2019-2021 | |
| Harrow Eye, LLC | $63.67 | 2025 | |
| Alcon Vision LLC | $46.29 | 2025 | Tryptyr |
| Sun Pharmaceutical Industries INC. | $44.48 | 2023 | Cequa |
| Novartis Pharmaceuticals Corporation | $20.57 | 2022 | |
| Tarsus Pharmaceuticals, INC. | $19.25 | 2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $17.36 | 2022 | |
| Galderma Laboratories, L.P. | $15.03 | 2019 | |
| New World Medical,INC. | $2.42 | 2024 | Ahmed Glaucoma Valve, Streamline, Clearpath |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Relief Jones listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.